… heparin can prevent VOD in BMT patients. Since low molecular weight heparin (LMWH)
preserves the antithrombotic, but not the anticoagulant, activity of unfractionated heparin, we …

… hepatic veno-occlusive disease (VOD) after BMT with three prophylactic regimens. Patients
… heparin (Hep), heparin + prostaglandin E1 (Hep + PGE1) or low molecular weight heparin (…

… weight heparin (LMWH) as hepatic veno-occlusive disease (VOD) prophylaxis. Patients
received a once daily subcutaneous injection of dalteparin 2500 anti-Xa iu commencing the day …

… Heparin, low-molecular-weight heparin, prostaglandin E1, ursodiol, and glutamine have
been studied for prevention of veno-occlusive disease. Heparin has been studied most …

… Hepatic veno-occlusive disease (VOD) is a common … heparin or ursodiol may reduce the
incidence of VOD. In order to compare the efficacy of heparin plus ursodiol with that of heparin …

… Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in
bone marrow transplantation patients. Transplantation 1996; 61: 1067–1071. …

… molecular weight heparin in patients with retinal vein occlusion. … occlusion were conducted.
We identified 1,084 references of which 3 studies comparing low molecular weight heparin …

… to use unfractionated heparin or low–molecular weight heparin for the treatment of cerebral
venous thrombosis. We examined the effect on clinical outcome of each type of heparin. …

… whether low molecular weight heparin (LMWH) could be equal or more effective than
conventional oral anticoagulants (OAs) in the long-term treatment of deep venous thrombosis (DVT)…

… 1984 who did not receive heparin, and a series of … heparin administration (n = 52) vs no
heparin (n = 46), and an additional group of 38 patients who received non-randomized heparin …